Aprogen Biologics Inc. (KRX:003060)
2,075.00
-80.00 (-3.71%)
Aug 12, 2026, 1:01 PM KST
-78.49% (1Y)
| Market Cap | 50.73B -58.9% |
| Revenue (ttm) | 78.00B +13.7% |
| Net Income | -131.21B |
| EPS | -9,961.73 |
| Shares Out | 23.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96,651 |
| Open | 2,145.00 |
| Previous Close | 2,155.00 |
| Day's Range | 2,060.00 - 2,160.00 |
| 52-Week Range | 1,869.00 - 10,395.00 |
| Beta | -0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |